喘息とアレルギー性鼻炎の制御における農村と都市における初等医療の実践の違い:ギリシャの経験
Eirini Lambraki1, Izolde Bouloukaki1, Katerina Margetaki1
1Health Planning Unit, Department of Social Medicine, School of Medicine, University of Crete, Crete, Greece.
Rural and remote health
|September 1, 2025
まとめ
喘息とアレルギー性鼻炎のコントロールは,特に農村部では,ギリシャのプライマリケアでは不十分です. 女性の性別と農村での居住は,よりよい制御と関連しており,鼻内ステロイドの使用は喘息の制御を改善しました.
科学分野:
- プライマリケア研究
- 呼吸器薬
- 流行病学
背景:
- 農村部における喘息とアレルギー性鼻炎の制御に関するデータは限られている.
- これらの併発性疾患の有効な管理は,患者のアウトカムにとって極めて重要です.
研究 の 目的:
- 都市部と農村部のギリシャのプライマリケア患者の喘息とアレルギー性鼻炎のコントロールを評価する.
- これらの状態の改善に伴う要因を特定する.
主な方法:
- 121人の喘息とアレルギー性鼻炎の患者を対象とした横断研究.
- 質問書は,人口統計,併発症,治療,症状制御 (ACT,ACQ,CARAT) を評価した.
- 多変量ロジスティック回帰では,コントロールに関連する要因が特定されました.
主要な成果:
- 54% (ACT) と67% (ACQ) が不適正なコントロールを報告し,88%が不適正なコントロールを報告した.
- 女性の性別と農村での居住は,よりよいコントロールと関連していた (CARAT).
- 鼻内ステロイドの使用は,よりよい喘息制御 (ACT) と相関しています.
結論:
- 喘息とアレルギー性鼻炎のコントロールは,ギリシャのプライマリケアでは最適ではありません.
- 居住地域,性別,薬物使用はコントロールに影響を与える重要な要因です.
- これらの要因を考慮した標的型の介入が 患者の成果を改善するために必要である.
関連する概念動画
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
Asthma-IV: Nursing Management
3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451


